思创医惠：关于使用部分闲置自有资金进行现金管理的公告

Core Viewpoint - The company announced the approval of a proposal to utilize part of its idle self-owned funds for cash management, with a total limit of up to 800 million RMB [1] Group 1 - The sixth board meeting is scheduled for August 21, 2025, where the cash management proposal will be reviewed [1] - The company and its subsidiaries will invest in high-security, high-liquidity, and low-risk financial products [1] - The usage period for the funds is valid for 12 months from the date of shareholder meeting approval, allowing for rolling use within the limit [1]